Bell Microproducts prelims point to recovery

News

Bell Microproducts prelims point to recovery

Microscope contributor

 

Bell Microproducts appears to have finally put the recent dark days of yesteryear behind it after posting preliminary fourth quarter stats that show sequential and annualised growth across nearly all geographies and many product divisions.

 

The enterprise distie has come through a costly investigation into accounting errors stretching back to the 1990s, was de-listed from NASDAQ as it fell out of compliance with the stock market’s regulations and only recently got SEC filings up-to-date.

 

Sales during the final calendar quarter of 2009 are expected to be $830m to $840m, an increase of approximately 8% to 10% and well above Bell’s original guidance.

 

“We have seen improvements in business in all geographies and most product categories,” said Don Bell, CEO at the US distributor.

 

Revenues in North America went up 3% on last quarter and 1% year-on-year, in Europe sales grew 17% sequentially and 13% on Q4 2008. In Latin America turnover went up 6% on Q3 and 19% on an annualised comparison.

 

The components and peripherals divisions increased sales 14% quarter-on-quarter and 26% on a year ago, while the solutions business unit grew the top line 6% sequentially but fell 1% year-on-year.

 


Join the conversation Comment

Share
Comments

    Results

    Contribute to the conversation

    All fields are required. Comments will appear at the bottom of the article.